Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetic Peripheral Neuropathy

In brief

The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating Painful DPN.

Key facts

Study ID
NCT05660538
Run by
Vertex Pharmaceuticals Incorporated
People needed
194
Starts
2022-12-20
Expected to finish
2023-10-25
Last updated by the study team
2025-07-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.